Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Journal
PharmacoEconomics
ISSN: 1179-2027
Titre abrégé: Pharmacoeconomics
Pays: New Zealand
ID NLM: 9212404
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
pubmed:
9
11
2019
medline:
2
4
2021
entrez:
9
11
2019
Statut:
ppublish
Résumé
The National Institute for Health and Care Excellence (NICE) invited Alimera Sciences, the company manufacturing fluocinolone acetonide intravitreal implant (FAc) 0.19 mg (tradename ILUVIEN
Identifiants
pubmed: 31701471
doi: 10.1007/s40273-019-00851-z
pii: 10.1007/s40273-019-00851-z
pmc: PMC7176320
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Drug Implants
0
Fluocinolone Acetonide
0CD5FD6S2M
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Pagination
431-441Subventions
Organisme : Department of Health
ID : 16/119/02
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Références
Value Health. 2009 Jul-Aug;12(5):793-9
pubmed: 19490557
Ophthalmology. 2016 Mar;123(3):655-62
pubmed: 26712559
Ophthalmology. 2015 Oct;122(10):1976-86
pubmed: 26298718
Ophthalmology. 2019 Apr;126(4):601-610
pubmed: 30367884
F1000Res. 2017 Mar 16;6:280
pubmed: 28357059
Health Technol Assess. 2016 Apr;20(26):1-48
pubmed: 27049841